BERNICE ESTEGHAMATDARSHAD: Open Payments
NPI 1598192387 · LAREDO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$844 in 33 payments from 7 companies in 2025. Trend: 2023 $610 · 2024 $704 · 2025 $844
Food & beverage: $844
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $331 |
| Novartis Pharmaceuticals Corporation | 13 | $308 |
| Amgen Inc. | 4 | $69 |
| GlaxoSmithKline, LLC. | 3 | $47 |
| ABBVIE INC. | 2 | $43 |
| UCB, Inc. | 1 | $28 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
Products named: TREMFYA, COSENTYX, TAVNEOS, BENLYSTA, Bimzelx, ILARIS, SKYRIZI, RINVOQ.
Industry payments across TX — which companies pay providers there.
